which then gives a first market for any biotech company. And then you can go global from there. Is there far too much uncertainty about the protection of your IP in India? I think the situation ...

Agenus (NASDAQ:AGEN) added ~21% in the premarket on Tuesday after the Massachusetts-based biotech announced a partnership ...

Concord Biotech share price rose on the back of a healthy March quarter of financial year 2025 (Q4FY25) results.

BENGALURU, Aug 18 (Reuters) - Shares of India's Concord Biotech (CONB.NS), opens new tab settled 27.2% higher at 942.8 rupees in their trading debut on Friday, valuing the biopharma company at ...

and Converge Biotech, a prominent healthcare company with a strong critical care and infectious disease focus in India, are pleased to announce a new strategic collaboration where the two ...

The Pharmexcil has taken the decision after the company failed to reply to the ... a cough syrup manufactured by Marion Biotech in India, the health ministry of Uzbekistan said Tuesday.